Share ownership Bio-Rad Laboratories, Inc. NYSE

BIO.B

US0905721082

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:10:00 2026-08-20 EDT			5-day change	1st Jan Change
365.08 ^USD	+8.33%		+8.33%	+17.50%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Share class: Bio-Rad Laboratories, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	25,204,989	18,131,081 ( 71.93 %)	3,527,852 ( 14 %)	60.2 %
Stock B	1	5,061,038	89,766 ( 1.774 %)	0

Major shareholders: Bio-Rad Laboratories, Inc.

Name	Stocks	%	Valuation
Blue Raven Partners LP 80.22 %	4,060,054	80.22 %	1 329 M $
Estate Of SCHWARTZ ALICE N 9.771 %	494,510	9.771 %	162 M $
Norman Schwartz 7.399 %	374,472	7.399 %	123 M $
Parametric Portfolio Associates LLC 3.774 %	190,997	3.774 %	63 M $
Wells Fargo Clearing Services LLC 3.157 %	159,767	3.157 %	52 M $
UBS Securities LLC 2.404 %	121,678	2.404 %	40 M $
Steven Schwartz 0.7556 %	38,240	0.7556 %	13 M $
Allison Schwartz 0.079 %	3,996	0.079 %	1 M $
Flow Traders U.S. LLC 0.015 %	760	0.015 %	248 721 $
Whittier Trust Co. 0.003161 %	160	0.003161 %	52 362 $

Name	Stocks	%	Valuation
Estate Of SCHWARTZ ALICE N 12.51 %	2,714,928	12.51 %	884 M $
First Eagle Investment Management LLC 12.01 %	2,606,219	12.01 %	848 M $
BlackRock Advisors LLC 7.335 %	1,591,640	7.335 %	518 M $
DFA Australia Ltd. 4.257 %	923,806	4.257 %	301 M $
Vanguard Capital Management LLC 3.811 %	826,972	3.811 %	269 M $
Ariel Investments LLC 3.764 %	816,751	3.764 %	266 M $
Vanguard Portfolio Management LLC 3.761 %	816,198	3.761 %	266 M $
EARNEST Partners LLC 2.676 %	580,752	2.676 %	189 M $
STATE STREET CORPORATION 2.635 %	571,762	2.635 %	186 M $
Managed Account Advisors LLC 2.26 %	490,412	2.26 %	160 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Others	90%
Institutional	9.35%
Individuals	8.23%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	99.35%
Individuals	8.23%

Based on 1000 largest holdings

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Employees

7,450

Sector

Medical Equipment, Supplies & Distribution

More about the company